ALLOInvestor Day
Cell therapy pipeline investor update
Allogene Therapeutics | Cema-cel | Large B-cell lymphoma
Catalyst details
Company event tracked from press releases and investor relations calendar.
Phase
Phase 2
Expected date
2026-07-24
Expected period
July 24, 2026
Source type
rss
exactupcoming
Source URLNotes
This record is structured for public-source tracking and manual analyst override. The database stores date confidence separately from exact dates so quarter, half-year, and estimated guidance can be handled without inventing precision.
Open company detail